Delayed Graft Function clinical trials

Explore recruiting delayed graft function clinical trials.

Recruiting delayed graft function studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Delayed Graft Function trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Alkaline Phosphatase as treatment of Ischemia Reperfusion Injury to prevent delayed graft function

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Assess the Safety, Efficacy, and Tolerability of ARGX-117 in Improving Allograft Function in Recipients of a Deceased Donor Renal Allograft at Risk for Delayed Graft Function (Varvara)

Belgium, Spain, Portugal, Italy, France, Austria +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function after Kidney Transplantation

Poland, Italy, Germany, Austria, Portugal, Czechia +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Mannitol versus normal saline in brain death donors and recipients of kidney allograft on delayed graft function (MAVERICK) – A double-blinded, placebo-controlled randomized clinical trial

Finland

Therapeutic use (Phase IV) EU CTIS Study details

Double-blind Placebo-Controlled Randomized Clinical Trial of Mineralocorticoid Receptor Blockade With Eplerenone After Renal Transplantation : Effect on Graft Function at 3 Months. EPURE TRANSPLANT

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A prospective, randomized, single blind, multicentre phase III study on organ preservation with Custodiol-N solution compared with Custodiol solution in or-gan transplantation (kidney, liver and pancreas)

Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Delayed Graft Function trials by city

Delayed Graft Function in Toronto Delayed Graft Function in Vancouver Delayed Graft Function in Montreal Delayed Graft Function in Calgary Delayed Graft Function in Edmonton Delayed Graft Function in Ottawa Delayed Graft Function in Winnipeg Delayed Graft Function in Quebec City Delayed Graft Function in Hamilton Delayed Graft Function in Kitchener Delayed Graft Function in London Delayed Graft Function in Halifax Delayed Graft Function in New York Delayed Graft Function in Los Angeles Delayed Graft Function in Chicago Delayed Graft Function in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease